AGD Joins Letter to Appropriators on Tobacco-FDA Provisions
The AGD joined Tobacco Free Kids and other health, medical, education, and community organizations in a letter to House appropriators urging them not to include any provisions in the fiscal year (FY) 2023 Agriculture, Rural Development, Food and Drug Administration (FDA), and Related Agencies Appropriations bill that would weaken FDA’s authority over tobacco products.
The FDA is granted authority under the Family Smoking Prevention and Tobacco Control Act (TCA) to regulate the manufacture, distribution, and marketing of tobacco products. Over the years, manufacturers and sellers of tobacco products have sought to exclude certain products from FDA’s authority or weaken the agency’s authority over them through the appropriations process.
Impact on General Dentistry: The AGD is pleased that the House FY 2023 Agriculture-Rural Development-FDA bill does not include provisions weakening FDA’s authority over tobacco products. AGD will continue to monitor and engage on tobacco specific issues during the Senate appropriations process.
The FDA is granted authority under the Family Smoking Prevention and Tobacco Control Act (TCA) to regulate the manufacture, distribution, and marketing of tobacco products. Over the years, manufacturers and sellers of tobacco products have sought to exclude certain products from FDA’s authority or weaken the agency’s authority over them through the appropriations process.
Impact on General Dentistry: The AGD is pleased that the House FY 2023 Agriculture-Rural Development-FDA bill does not include provisions weakening FDA’s authority over tobacco products. AGD will continue to monitor and engage on tobacco specific issues during the Senate appropriations process.